Cargando…
Hodgkin Disease—An Ever-Evolving Therapy
Therapy of Hodgkin lymphoma (HL) is a rapidly changing field due to plenty of currently emerging data. Treatment approaches are currently based on tailoring of therapy in order to achieve a maximal response with minimal toxicity. Since the median age of HL patients is 33 years and their prospective...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Rambam Health Care Campus
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222418/ https://www.ncbi.nlm.nih.gov/pubmed/25386345 http://dx.doi.org/10.5041/RMMJ.10163 |